Inventor · disambiguated record
Josef Vagner
Also filed as: VAGNER JOSEF
15 granted patents·7 pending applications·138 citations·filing 1999–2024
90Inventor score
Files withH LEE MOFFITT CANCER CT & RES8UNIV ARIZONA8NOVO NORDISK AS2GILLIES ROBERT J1MORSE DAVID L1
Top patents by PatentIndex Score
22 records- 0195US6503949B1Glucagon antagonists/inverse agonistsNORO NORDISK AS·Filed 2000·Granted Jan 7, 2003·67 cites·56 claims
- 0288US6225329B1Modulators of protein tyrosine phosphatases (PTPases)NOVO NORDISK AS·Filed 1999·Granted May 1, 2001·58 cites·13 claims
- 0387US10118942B2Toll-like receptor 2 ligands and methods of making and using thereofH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Nov 6, 2018·4 cites·12 claims
- 0487US2025129118A1Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 0583US10793595B2Toll-like receptor 2 ligands and methods of making and using thereofH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Oct 6, 2020·2 cites·12 claims
- 0678US12173087B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Dec 24, 2024·0 cites·18 claims
- 0776US10406248B2Molecular imaging of cancer cells in vivoMORSE DAVID L·Filed 2012·Granted Sep 10, 2019·4 cites·22 claims
- 0874US11230568B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Jan 25, 2022·0 cites·18 claims
- 0973US9441013B2Melanocortin 1 receptor ligands and methods of useGILLIES ROBERT J·Filed 2012·Granted Sep 13, 2016·2 cites·16 claims
- 1069US11458212B2Molecular imaging of cancer cells in vivoH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Oct 4, 2022·0 cites·13 claims
- 1168US11414455B2Toll-like receptor 2 ligands and methods of making and using thereofH LEE MOFFITT CANCER CT & RES·Filed 2020·Granted Aug 16, 2022·0 cites·10 claims
- 1267US10308656B2Small molecule inhibitors of Ku70/80 and uses thereofUNIV ARIZONA·Filed 2016·Granted Jun 4, 2019·1 cites·9 claims
- 1360US2009143592A1Glucagon Antagonists/Inverse AgonistsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1459US10329326B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Jun 25, 2019·0 cites·8 claims
- 1555US2024269242A1Compositions and methods for treating and preventing lung diseaseUNIV ARIZONA·Filed 2024·Application pending·0 cites
- 1654US2005203108A1Glucagon antagonists/inverse agonistsFiled 2004·Application pending·0 cites
- 1747US11952379B2Small molecule modulators of PAR2 and uses thereofUNIV ARIZONA·Filed 2019·Granted Apr 9, 2024·0 cites·22 claims
- 1846US2022274991A1Small molecule inhibitors of ku70/80 and uses thereofUNIV ARIZONA·Filed 2020·Application pending·0 cites
- 1943US2023135877A1Compositions and methods for treating and preventing lung diseaseUNIV ARIZONA·Filed 2021·Application pending·0 cites
- 2041US2019307426A1Imaging system using receptor-targeted microbubblesUNIV ARIZONA·Filed 2017·Application pending·0 cites
- 2137US11351264B2PAR2 mimetic peptides and uses thereofUNIV ARIZONA·Filed 2017·Granted Jun 7, 2022·0 cites·6 claims
- 2235US11306130B2PAR3 mimetic peptides and uses thereofUNIV ARIZONA·Filed 2017·Granted Apr 19, 2022·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Josef Vagner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →